Alexandria Venture Investments Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 7
- Investments
- 312
- Portfolio
- 141
- Exits
- 98
Alexandria Venture Investments General Information
Description
Founded in 1996, Alexandria Venture Investments is a venture capital firm based in Pasadena, California. The firm prefers to invest in seed-stage, early-stage, and growth-stage companies. The firm also seeks to invest in healthcare, information technology, materials, and resources sectors.
Contact Information
Year Founded
1996
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 26 North Euclid Avenue
- Pasadena, CA 91101
- United States
+1 (626) 000-0000
Alexandria Venture Investments Investments (312)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Pleno | 25-May-2022 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | |
| 00000 000000000000 | 17-May-2022 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| 0000 000000000000 | 10-May-2022 | 00000 00000 | 00000 | Drug Discovery | Startup | |
| 00000 000000000000 | 01-Apr-2022 | 00000 00000 | 00000 | Drug Discovery | Pre-Clinical Trials | |
| 0000000 (000000000 | 24-Mar-2022 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 000000 000 | 08-Mar-2022 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 0000000 | 08-Mar-2022 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 000000 00000000000 | 15-Feb-2022 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue | |
| Ventus Therapeutics | 09-Feb-2022 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue | |
| Kallyope | 27-Jan-2022 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue |
Alexandria Venture Investments Exits (98)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Yesse Technologies | 13-May-2022 | Out of Business | |
| 0000 0000000000 | 01-Apr-2022 | 000000000000000000 | |
| 0000000 0000000000 | 24-Mar-2022 | 000 00 00000000 | |
| 0000000000 0000000 | 04-Feb-2022 | 0000000 000000 | 00000 |
| 00000 00000 | 07-Jan-2022 | 000 | 0000 |
| 00000 | 31-Dec-2021 | 000 00 00000000 | |
| 0000 | 17-Dec-2021 | 0000000 000000 | 00.00 |
| 0000000 0000000000 | 04-Nov-2021 | 000 | 00000 |
| Aura Biosciences | 02-Nov-2021 | IPO | 000.00 |
| Blackthorn Therapeutics | 07-Oct-2021 | Merger/Acquisition |
Alexandria Venture Investments Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialAlexandria Venture Investments Team (9)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Jenna Foger | Senior Vice President, Science & Technology | 0 | Pasadena, CA | ||
| Monica Beam Ph.D | Senior Vice President, Science & Technology | 0 | Pasadena, CA | ||
| Aaron Jacobson | Senior Vice President, Venture Counsel | Pasadena, CA | |||
| Jeff Stevens | Vice President, Science & Technology | 0 | 0 | Pasadena, CA | |
| Dean Shigenaga | President & Chief Financial Officer, Alexandria Real Estate Equities | Pasadena, CA |
Alexandria Venture Investments Co-Investors (636)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 23 | 0 | 0 |
|
|
| Casdin Capital | 00 | 0 | 0 |
|
|
| GV | 00 | 0 | 0 |
|
|
| RA Capital Management | 00 | 0 | 0 |
|
|
| Pfizer Ventures | 00 | 0 | 00 |
|
|